Factor XIa as a possible new target of antithrombotic therapy

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 7, 2006, Pages 1494-1495

  Goto, Shinya ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 11A INHIBITOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; FIBRIN; FIBRINOGEN RECEPTOR ANTAGONIST; PROTHROMBIN; UNCLASSIFIED DRUG; WARFARIN;

ANTICOAGULATION; ARTERY DISEASE; ARTERY THROMBOSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; DRUG TARGETING; FIBRIN FORMATION; HEART INFARCTION; HEMOSTASIS; HUMAN; INHIBITION KINETICS; NOTE; PRIORITY JOURNAL; PROTHROMBIN TIME; RABBIT; RISK BENEFIT ANALYSIS; THROMBOCYTE AGGREGATION INHIBITION; VEIN THROMBOSIS;

ANIMALS; FACTOR XIA; FIBRIN; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; PLATELET ACTIVATION; THROMBOSIS;

EID: 33745253758     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02027.x     Document Type: Note

References (17)

1. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180-9.
2. Fuster V, Moreno PR. Atherothrombosis as a systemic, often silent, disease. Nat Clin Pract Cardiovasc Med 2005; 2: 431.
3. Goto S. Propagation of arterial thrombi: Local and remote contributory factors. Arterioscler Thromb Vasc Biol 2004; 24: 2207-8.
4. Goto S. Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 149-56.
5. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
6. Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet 1999; 353: 227-31.
7. Gurbel PA, Serebruany VL. Oral platelet IIb/IIIa inhibitors: From attractive theory to clinical failures. J Thromb Thrombolysis 2000; 10: 217-20.
8. Hoshiba Y, Hatakeyama K, Tanabe T, Asada Y, Goto S. Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction. J Thromb Haemost 2006; 4: 114-20.
9. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190-7.
10. Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S, Ruggeri ZM. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J Thromb Haemost 2003; 1: 2022-30.
11. Yamashita A, Nishihira K, Kitazawa T, Yoshihashi K, Soeda T, Esaki K, Imamura T, Hattori K, Asada Y. Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery. J Thromb Haemost 2006; 4: 1496-1501.
12. Gruber A, Hanson SR. Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. Blood 2003; 102: 953-5.
13. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19: 170-7.
14. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003; 107: 1692-711.
15. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 1985; 65: 719-24.
16. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds - a clinical and laboratory study. Thromb Haemost 1995; 73: 194-202.
17. Mannucci PM, Bauer KA, Santagostino E, Faioni E, Barzegar S, Coppola R, Rosenberg RD. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 1994; 84: 1314-9.